Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · IEX Real-Time Price · USD
12.56
-1.05 (-7.71%)
At close: Apr 24, 2024, 4:00 PM
12.57
+0.01 (0.08%)
After-hours: Apr 24, 2024, 7:23 PM EDT
Phibro Animal Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for PAHC stock have an average target of 18.5, with a low estimate of 16 and a high estimate of 21. The average target predicts an increase of 47.29% from the current stock price of 12.56.
Analyst Consensus: Buy
* Price targets were last updated on Nov 9, 2023.
Analyst Ratings
The average analyst rating for PAHC stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $16 | Hold | Maintains | $17 → $16 | +27.39% | Nov 9, 2023 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +67.20% | Sep 1, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | +35.35% | Aug 31, 2023 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +67.20% | Aug 29, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $18 | Hold | Reiterates | $18 | +43.31% | Jul 27, 2023 |
Financial Forecast
Revenue This Year
1.02B
from 977.89M
Increased by 4.20%
Revenue Next Year
1.05B
from 1.02B
Increased by 3.24%
EPS This Year
1.12
from 0.81
Increased by 38.83%
EPS Next Year
1.26
from 1.12
Increased by 12.02%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.1B | 1.1B | 1.1B |
| Avg | 1.0B | 1.1B | 1.1B |
| Low | 975.1M | 986.9M | 1.0B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 7.7% | 7.7% | 7.1% |
| Avg | 4.2% | 3.2% | 3.0% |
| Low | -0.3% | -3.2% | -2.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.19 | 1.46 | 1.60 |
| Avg | 1.12 | 1.26 | 1.42 |
| Low | 1.07 | 1.10 | 1.29 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 46.5% | 29.8% | 26.7% |
| Avg | 38.8% | 12.0% | 12.6% |
| Low | 31.9% | -2.4% | 2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.